Furthermore, the liver enzymes CYP3A4 and CYP3A5 are also trapped in the drug metabolism of T-DM1, and patients with mutations in these two genes are susceptible to AEs associated with T-DM1, especially thrombocytopenia. The gene discussed is CYP3A5; the disease is Thrombocytopenia.